High-risk neuroblastoma therapeutics, topotecan and 13-cis retinoic acid, modulate autophagy through epigenetic changes in cord blood-derived hematopoietic stem and progenitor cells and 13-cis-retinoic acid potentiates monocyte aktivity-MedSci.cn

High-risk neuroblastoma therapeutics, topotecan and 13-cis retinoic acid, modulate autophagy through epigenetic changes in cord blood-derived hematopoietic stem and progenitor cells and 13-cis-retinoic acid potentiates monocyte aktivity

Laznickova, P; Bendickova, K; Kohoutkova, MH; De Zuani, M; Jose, SS; Kepak, T; Krenova, Z; Fric, J

EUROPEAN JOURNAL OF IMMUNOLOGY, 2023; 53 (): 116

科室
- - 订阅+
  - 更多科室
工具
服务